JP2001525325A5 - - Google Patents

Download PDF

Info

Publication number
JP2001525325A5
JP2001525325A5 JP2000523217A JP2000523217A JP2001525325A5 JP 2001525325 A5 JP2001525325 A5 JP 2001525325A5 JP 2000523217 A JP2000523217 A JP 2000523217A JP 2000523217 A JP2000523217 A JP 2000523217A JP 2001525325 A5 JP2001525325 A5 JP 2001525325A5
Authority
JP
Japan
Prior art keywords
benzothieno
pyrimidin
tetrahydro
chloro
ethanolamine salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000523217A
Other languages
English (en)
Japanese (ja)
Other versions
JP4314341B2 (ja
JP2001525325A (ja
Filing date
Publication date
Priority claimed from DE19752952A external-priority patent/DE19752952A1/de
Application filed filed Critical
Publication of JP2001525325A publication Critical patent/JP2001525325A/ja
Publication of JP2001525325A5 publication Critical patent/JP2001525325A5/ja
Application granted granted Critical
Publication of JP4314341B2 publication Critical patent/JP4314341B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000523217A 1997-11-28 1998-11-19 チエノピリミジン類 Expired - Fee Related JP4314341B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19752952A DE19752952A1 (de) 1997-11-28 1997-11-28 Thienopyrimidine
DE19752952.6 1997-11-28
PCT/EP1998/007436 WO1999028325A1 (de) 1997-11-28 1998-11-19 Thienopyrimidine

Publications (3)

Publication Number Publication Date
JP2001525325A JP2001525325A (ja) 2001-12-11
JP2001525325A5 true JP2001525325A5 (enExample) 2008-12-18
JP4314341B2 JP4314341B2 (ja) 2009-08-12

Family

ID=7850200

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000523217A Expired - Fee Related JP4314341B2 (ja) 1997-11-28 1998-11-19 チエノピリミジン類

Country Status (24)

Country Link
US (2) US6420368B1 (enExample)
EP (1) EP1036078B1 (enExample)
JP (1) JP4314341B2 (enExample)
KR (1) KR20010032445A (enExample)
CN (1) CN1138780C (enExample)
AR (1) AR010962A1 (enExample)
AT (1) ATE361926T1 (enExample)
AU (1) AU742433B2 (enExample)
BR (1) BR9815409A (enExample)
CA (1) CA2311922C (enExample)
CO (1) CO4980884A1 (enExample)
CZ (1) CZ291068B6 (enExample)
DE (2) DE19752952A1 (enExample)
ES (1) ES2285796T3 (enExample)
HK (1) HK1038924A1 (enExample)
HU (1) HUP0100488A3 (enExample)
ID (1) ID24571A (enExample)
NO (1) NO20002702D0 (enExample)
PL (1) PL341156A1 (enExample)
RU (1) RU2217431C2 (enExample)
SK (1) SK7772000A3 (enExample)
TW (1) TW472059B (enExample)
WO (1) WO1999028325A1 (enExample)
ZA (1) ZA9810845B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19819023A1 (de) 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
CA2365578A1 (en) 1999-03-30 2000-10-12 Seiichi Uchida Thienopyrimidine compounds and salts thereof and process for the preparation of the same
DE19942474A1 (de) * 1999-09-06 2001-03-15 Merck Patent Gmbh Pyrazolo[4,3-d]pyrimidine
CN1436080A (zh) 2000-04-19 2003-08-13 利利艾科斯有限公司 环gmp-特异性磷酸二酯酶抑制剂治疗帕金森氏病的用途
DE10031584A1 (de) 2000-06-29 2002-01-10 Merck Patent Gmbh 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
DE10031585A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-Aminoalkyl-thieno[2,3-d]pyrimidine
DE10042997A1 (de) * 2000-09-01 2002-03-14 Merck Patent Gmbh Thienopyrimidine
CA2423981A1 (en) * 2000-09-29 2003-03-28 Kimiko Ichikawa Thienopyrimidine compounds and salts thereof and process for the preparation of the same
DE10058663A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Thienopyrimidinen
AU2002227957A1 (en) * 2000-12-19 2002-07-01 Merck Patent Gmbh Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
DE10064994A1 (de) * 2000-12-23 2002-07-04 Merck Patent Gmbh Sulfamidothienopyrimidine
DE10103647A1 (de) 2001-01-27 2002-08-01 Merck Patent Gmbh Verfahren zur Herstellung eines Pyrazolo (4,3-d) pyrimidinderivates
WO2002060449A2 (de) * 2001-01-31 2002-08-08 Merck Patent Gmbh Pharmazeutische formulierung enthaltend pyrazolo[4,3-d]pyrimidine und nitrate oder thienopyrimidine und nitrate
CN101100472A (zh) * 2001-04-30 2008-01-09 美国拜尔公司 4-氨基-5,6-取代的噻吩并[2,3-d]嘧啶化合物及其应用
DE10148883A1 (de) * 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
JPWO2003035653A1 (ja) * 2001-10-26 2005-02-10 日本曹達株式会社 ピリドチエノピリミジン化合物およびその塩
KR100824193B1 (ko) 2003-04-29 2008-04-21 화이자 인코포레이티드 고혈압 치료에 유용한5,7-디아미노피라졸로[4,3-d]피리미딘
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
JP2007532526A (ja) 2004-04-07 2007-11-15 ファイザー・インク ピラゾロ[4,3−d]ピリミジン類
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
ES2259891B1 (es) * 2004-11-30 2007-11-01 Laboratorios Almirall S.A. Nuevos derivados de piridotienopirimidina.
ES2259892B1 (es) * 2004-11-30 2007-11-01 Laboratorios Almirall S.A. Nuevos derivados de piridotienopirimidina.
US9056877B2 (en) 2011-07-19 2015-06-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN109297923A (zh) * 2018-09-19 2019-02-01 南通出入境检验检疫局检验检疫综合技术中心 纺织品中微量含氟整理剂的测定方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE245666C (enExample)
DD245666A1 (de) * 1985-09-20 1987-05-13 Univ Halle Wittenberg Verfahren zur herstellung von 4-aminosubstituierten thieno 2,3-d-pyrimidin-2-ylessigsaeureestern
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19644228A1 (de) 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine

Similar Documents

Publication Publication Date Title
IL287708A (en) Janus kinase inhibitor salts
TWI365188B (en) Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
AU6890800A (en) A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-D]- pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor
PL1611144T3 (pl) Pochodne kwasu 2-(8,9-diokso-2,6-diazabicyklo(5.2.0)non-1(7)-en-2-ylo)alkilofosfonowego i ich zastosowanie jako antagonistów receptora N-metylo-D-asparaginianu (NMDA)
HK1049158A1 (zh) 药物活性异二氢吲衍生物
JP2007524571A5 (enExample)
ME02688B (me) Hinazolinoni kao inhibitori humane fosfatidilinozitol 3 - kinaze delta
DK1210068T3 (da) Anvendelse af simple aminosyrer til dannelse af poröse partikler
CY2017011I2 (el) 2-(ΠΥΡΙΔΙΝ-2-ΥΛΑΜΙΝΟ)-ΠΥΡΙΔΟ[2,3-d]ΠΥΡΙΜΙΔΥΝ-7-ΟΝΕΣ
JP2007510401A5 (enExample)
MXPA05010422A (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad.
JP2006298933A5 (enExample)
PL354362A1 (en) Oral dosage forms
WO2001094345A3 (en) Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
WO2009113051A3 (en) Oral modified-release formulations containing thiazepines
JP2005508955A5 (enExample)
MA33385B1 (fr) Acide trans-4-[[(5s)-5-[[[3,5-bis (trifluorométhyl) phényl] méthyl] (2-méthyl-2h-tétrazol-5-yl) amino]-2,3,4,5-tétrahydro-7,9-diméthyl-1h-1-benzazépin-1-yl] méthyl]-cyclohexane carboxylique
AR032482A1 (es) Uso de tienopirimidinas
IL172167A0 (en) Pharmaceutically useful salts of carboxylic acid derivatives
WO2003099265A3 (de) Pharmazeutische wirkstoffkombination sowie deren verwendung
JP2002513761A5 (enExample)
CO5200845A1 (es) Derivados del acido monociclico 4-fenilbutanoico como antagonista del receptor vitronectina
JP2004505083A5 (enExample)
CA2547194A1 (en) Pharmaceutical oral dosage form comprising a non-steroidal anti-inflammatory drug, and having good palatability
WO2001012192A3 (en) Pharmaceutical compositions comprising a-(2-aminoethyl)-benzothiazolone and disodium cromoglycate or nedocromil